EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation


Journal of Nutrition 127(5 Suppl): 962s-965s
Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation
Reactive oxygen and nitrogen metabolites play a complex role in many diseases and in metabolic regulation. Because viruses replicate in living cells, such metabolites influence the growth of viruses in addition to serving as a host defense mechanism. Low levels of reactive oxygen species (ROS) play a role in mitogenic activation, and the early phase of lytic and nonlytic virus infection indeed resembles that of mitogenic cell activation. In addition to these subtle cell-activating effects shared by many viruses, influenza and paramyxoviruses activate a respiratory burst in phagocytic cells. These viruses are toxic when injected in animals. Cells lavaged from the lungs of mice infected with influenza virus are primed for enhanced superoxide generation. Moreover, xanthine oxidase is enhanced and the buffering capacity of small molecular antioxidants is decreased in the lungs, suggesting that infection leads to oxidative stress. The wide array of cytokines produced in the lungs during influenza could contribute to the systemic effects of influenza. Oxidative stress has also been shown in human immunodeficiency virus (HIV) infection in humans. Via activation of NF KB, ROS may activate viral replication, but oxidants are believed to contribute also to the loss of CD4 T cells by apoptosis. Antioxidants, together with agents interfering with the harmful effects of cytokines and lipid mediators, may have a role in the treatment of viral diseases. Such agents could not only alleviate disease symptoms but also decrease the long-term effects of chronic oxidative stress, which have been linked to the development of cancer in some viral infections. Reprinted by permission of the publisher.


Accession: 002914061

PMID: 9164274

DOI: 10.1093/jn/127.5.962S



Related references

2nd International Meeting on Free Radicals in Health and Disease. The role of oxidants and antioxidants in the regulation of chronic diseases, may 8-12, 2002, Istanbul, Turkey. Free Radical Research 37(4): 349-354, 2003

Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox Biology 1: 244-257, 2013

Oxidants and antioxidants in metabolic syndrome and cancer. Oxidative Medicine and Cellular Longevity 2014: 178962-178962, 2015

Cellular and molecular mechanisms of oxidants and antioxidants. Mineral and Electrolyte Metabolism 23(3-6): 135-139, 1997

Oxidants and antioxidants in rheumatic diseases. Free Radical Biology & Medicine 9(SUPPL 1): 187, 1990

Oxidants, antioxidants and diseases--a brief review. Indian Journal of Medical Sciences 51(7): 226-230, 1997

Oxidants, antioxidants and growth regulation. Proc. 4th internat. Conf. Plant Growth Regulation, 1961. 341-53. bibl.30, 1961

Biological oxidants and antioxidants: molecular mechanisms and health effects. Biological oxidants and antioxidants: molecular mechanisms and health effects: xii + 372 pp., 1998

Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences of the United States of America 90(17): 7915-7922, 1993

Oxidants and antioxidants in immune regulation and immunopathology. Biological Chemistry Hoppe-Seyler 373(9): 740-741, 1992